Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
Summary
Clearmind Medicine entered into securities purchase agreements with institutional investors for up to $10 million in convertible notes. The company completed an initial closing and expects additional issuances after its registration statement becomes effective. It plans to use the proceeds for working capital, general corporate purposes, and potential acquisitions. The announcement also says the company remains focused on strategic opportunities and building its intellectual property portfolio.
Funding
Amount
$10.0M
Total raised
Date
September 19, 2025
Announcement date
Investors
-
Lead investors
Company
clearmindmedicine.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected